申请人:E. R. Squibb & Sons, Inc.
公开号:US04607048A1
公开(公告)日:1986-08-19
7-Oxabicycloheptane substituted aryl amino prostaglandin analogs are provided having the structural formula ##STR1## wherein A is --CH.dbd.CH-- or --(CH.sub.2).sub.2 --; m is 1 to 8; n is 1 to 5; R is H, lower alkyl, alkali metal or a polyhydroxyamino salt; R.sup.1 is H, lower alkyl, hydroxyalkyl or aryl; R.sup.2 is H, lower alkyl, aryl or cycloalkyl, R.sup.3 is substituted aryl wherein the aryl group (which may be phenyl or naphthyl) is substituted with one or two of the following groups: hydroxy, ##STR2## SR.sup.4, --CN, --NO.sub.2, ##STR3## wherein R.sup.4 and R.sup.5 may be the same or different and are H or lower alkyl, and including all stereoisomers thereof. The compounds are cardiovascular agents useful, for example, in the treatment of thrombotic disease.
提供了7-Oxabicycloheptane取代芳基氨基前列腺素类似物,其具有结构式##STR1##其中A为--CH.dbd.CH--或--(CH.sub.2).sub.2--; m为1至8; n为1至5; R为H,低烷基,碱金属或多羟基氨基盐; R.sup.1为H,低烷基,羟基烷基或芳基; R.sup.2为H,低烷基,芳基或环烷基,R.sup.3为取代芳基,其中芳基(可能为苯基或萘基)被以下一种或两种基团取代:羟基,##STR2## SR.sup.4,--CN,--NO.sub.2,##STR3##其中R.sup.4和R.sup.5可以相同也可以不同,为H或低烷基,并包括所有立体异构体。这些化合物是心血管药物,例如,在治疗血栓性疾病中有用。